SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending as traders focus on its low float, anticipating a potential breakout and significant upward price movement. The community is actively discussing entry points, key breakout levels, and potential price targets, with some comparing it to other low-float stocks that have experienced substantial gains. A recent land sale and a shareholder meeting are also contributing to the increased interest.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to takeover speculation fueled by a Betaville rumor mentioning a large American pharmaceutical company as a potential suitor. The community is discussing the validity of the rumor and comparing the stock's potential to previous significant runs in the biotech sector. Some investors hope for a buyout, while others prefer the company to remain independent for further growth.

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Align Technology, Inc.

ALGN is trending as the community discusses recent price movement and future prospects, with some users drawing comparisons to SmileDirectClub's bankruptcy. Bullish investors point to share buybacks and insider buying as potential catalysts, while bears cite concerns about competition and market saturation. Discussions also include potential price targets and reactions to news from analysts.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as community members debate the impact of a recent reverse stock split and discuss the company's leadership. Some investors express confidence due to Saudi PIF backing and recent commercials, while others voice concerns about the company's financial performance and potential dilution. News of increased Gravity SUV production and a closed Uber investment are also circulating among investors.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAL is trending as the community discusses its potential in early cancer detection, highlighted by a recent article and a story about its life-saving importance. Some traders are taking profits, anticipating a retest, while others see long-term potential, particularly with possible FDA approval and broader access to its Galleri test. Volume and news catalysts are key talking points for future price movement.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Recent discussions around DJT center on its perceived overvaluation and the impact of political events, including scrutiny of connections to Jeffrey Epstein, driving volatility. Community members debate the stock's long-term potential amid economic concerns, potential tariffs and comparing the stock to the performance of the overall market. The opinions shared vary significantly with some suggesting it is a valuable investment, with others believing it is a failing enterprise.

GFL Environmental, Inc. engages in the business of transporting, managing, and recycling of solid and liquid waste and the provision of soil remediation services. It operates through the following segments: Solid Waste, Environmental Services, and Corporate. The Solid Waste segment includes hauling, landfill, transfers, and material recovery facilities. The Environmental Services segment provides liquid waste management and soil remediation services. The company was founded by Patrick Dovigi on December 19, 2007 and is headquartered in Vaughan, Canada.

GFL Environmental Inc. - Ordinary Shares (Sub Voting)

GFL is trending due to positive analyst ratings and raised price targets, with community members discussing the potential for a breakout. Recent reports highlight the company's growth strategy, M&A activity, and focus on balance sheet improvements. Discussions also mention GFL's position in the defensive waste management sector and its expansion into renewable energy projects.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as community members speculate on the potential impact of upcoming ophthalmology health conferences and data readouts, particularly regarding their pipeline including Tarcocimab and KSI-101. Bullish investors are encouraged by recent gains and are hoping for positive news, while others discuss potential buyouts and short squeezes. The stock's history of volatility and long-term prospects remain a key point of discussion.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending due to positive data from its EXPLORE44 trial, demonstrating significant improvements in key biomarkers for Duchenne muscular dystrophy. Community discussions highlight the potential for a buyout, particularly by Novartis, fueled by unusual options activity and analyst upgrades. The company's AOC platform and upcoming catalysts are also key talking points, placing $RNA in the spotlight within the muscular dystrophy space.

Cyngn, Inc. engages in the development of autonomous driving software that can be deployed on multiple vehicle types in various environments. The company was founded by Kirt McMaster and Steve Kondik in 2013 and is headquartered in Mountain View, CA.

Cyngn Inc

CYN is trending due to a recent $300M mixed securities shelf offering, sparking concerns among investors about potential dilution and reverse stock splits. The community is actively discussing the implications of this offering, its effect on the stock's price, and the company's long-term financial stability. Despite a collaboration with NVIDIA, the stock's history of dilution and reverse splits remains a key point of discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Verisk (VRSK) Down 4.5% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Corpay Earnings Meet Estimates in Q2, Revenues Increase 13% Y/Y

CPAY posts second-quarter 2025 earnings in line with estimates, lifts the 2025 revenue and EPS guidance despite mixed segmental results.

Avis Budget Stock Declines 22% Since Reporting Q2 Earnings Miss

CAR plunges 22% after second-quarter 2025 earnings and revenues miss estimates despite a nearly 98% YTD surge in shares.

Gartner Earnings Surpass Estimates in Q2, Revenues Increase Y/Y

IT posts strong second-quarter 2025 with EPS up 18.5% and revenues rising 5.6% y/y, but trims its full-year revenue and EBITDA guidance.

TRU Stock Barely Moves Since Reporting Q2 Earnings Beat: Here's Why

TransUnion beats second-quarter 2025 estimates and raises guidance, but the stock barely budged. Read to know what is holding back its momentum.

S&P Global Q2 Earnings & Revenues Outpace Estimates, Increase Y/Y

SPGI posts 9.7% EPS growth and strong segment gains in second-quarter 2025, and raises its yearly earnings outlook.

Verisk Earnings & Revenues Surpass Estimates in Q2, Increase Y/Y

VRSK posts 8.1% y/y EPS growth in second-quarter 2025, and lifts its revenue and EBITDA guidance despite a lowered EPS outlook.

Verisk Analytics (VRSK) Q2 Earnings and Revenues Beat Estimates

Verisk (VRSK) delivered earnings and revenue surprises of +6.21% and +0.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Verisk Set to Report Q2 Earnings: Here's What You Should Know

VRSK is set to report second-quarter 2025 results, with y/y revenue growth driven by subscriptions, pricing gains and client expansion.

Here's Why Verisk Analytics (VRSK) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Verisk Analytics, Inc. engages in the provision of data, analytics, and technology services. The firm also offers predictive analytics and decision support solutions to clients in rating, underwriting, claims, catastrophe, and weather risk fields. It operates through the Insurance segment. The Insurance segment offers fraud-detection solutions including review of data on claim histories, analysis of claims to find emerging patterns of fraud, and identification of suspicious claims in the insurance sector and offers solutions and services primarily through annual subscriptions or long-term agreements. The company was founded in 1971 and is headquartered in Jersey City, NJ.

VRSK
Verisk Analytics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VRSK News

VRSK Verisk Analytics Inc